Market closed
TherapeuticsMD Inc./$TXMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Ticker
$TXMD
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
1
Website
TXMD Metrics
BasicAdvanced
$11M
-
-$0.19
0.95
-
Price and volume
Market cap
$11M
Beta
0.95
52-week high
$1.15
52-week low
$0.72
Average daily volume
47K
Financial strength
Current ratio
2.373
Quick ratio
1.669
Long term debt to equity
20.248
Total debt to equity
26.215
Management effectiveness
Return on assets (TTM)
-5.31%
Return on equity (TTM)
-8.16%
Valuation
Price to revenue (TTM)
6.483
Price to book
0.42
Price to tangible book (TTM)
0.5
Price to free cash flow (TTM)
15.597
Growth
Revenue change (TTM)
35.25%
Earnings per share change (TTM)
-80.84%
3-year revenue growth (CAGR)
-11.87%
3-year earnings per share growth (CAGR)
-79.41%
TXMD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for TherapeuticsMD Inc. stock?
TherapeuticsMD Inc. (TXMD) has a market cap of $11M as of April 17, 2025.
What is the P/E ratio for TherapeuticsMD Inc. stock?
The price to earnings (P/E) ratio for TherapeuticsMD Inc. (TXMD) stock is 0 as of April 17, 2025.
Does TherapeuticsMD Inc. stock pay dividends?
No, TherapeuticsMD Inc. (TXMD) stock does not pay dividends to its shareholders as of April 17, 2025.
When is the next TherapeuticsMD Inc. dividend payment date?
TherapeuticsMD Inc. (TXMD) stock does not pay dividends to its shareholders.
What is the beta indicator for TherapeuticsMD Inc.?
TherapeuticsMD Inc. (TXMD) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.